MODIFI BIOSCIENCES INC
New Haven, United States · Founded 2022
- Headquarters
- New Haven, Connecticut
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- modifibio.com
About
Modifi Biosciences was a Yale University spinout developing novel small molecules targeting cancer cells lacking MGMT DNA repair protein expression. Their therapeutics exploit tumor-associated DNA repair defects, with research validated in Science (2022) and multiple pre-clinical tumor models. The company was acquired by Merck in October 2024 for $30M upfront plus up to $1.3B in milestones.
Summary
MODIFI BIOSCIENCES INC is a Biotech company based in New Haven, United States, founded in 2022.
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/modifi-biosciences-inc"><img src="https://indexed.vc/api/badge/company/modifi-biosciences-inc" alt="MODIFI BIOSCIENCES INC on Indexed.vc" width="260" height="76" /></a>